Eric Letouze

Nantes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

Journal: Blood cancer journal

Published: January 07, 2026

EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer.

EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer.

Journal: EMBO molecular medicine

Published: February 25, 2025

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.

Journal: The New England journal of medicine

Published: February 12, 2025

CRCI2NA inaugural symposium: A meeting on tumor and immune ecosystems.

CRCI2NA inaugural symposium: A meeting on tumor and immune ecosystems.

Journal: Biology of the cell

Published: August 28, 2024

Role and timing of chromosome deletions in multiple myeloma.

Role and timing of chromosome deletions in multiple myeloma.

Journal: Blood

Published: August 15, 2024

Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications.

Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications.

Journal: Blood advances

Published: December 12, 2023

Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Journal: Nature cancer

Published: September 08, 2023

Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Journal: Nature cancer

Published: May 23, 2023

Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.

Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.

Journal: Nature communications

Published: April 06, 2023

Discovering cryptic splice mutations in cancers via a deep neural network framework.

Discovering cryptic splice mutations in cancers via a deep neural network framework.

Journal: NAR cancer

Published: October 26, 2022

Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma.

Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma.

Journal: Nature communications

Published: October 07, 2022

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 28, 2022

Showing 1-12 of 88

Last Updated: 09/26/2026